The phylogeography and incidence of multi-drug resistant typhoid fever in sub-Saharan Africa

Autor: Park, SE, Pham, DT, Boinett, C, Wong, VK, Pak, GD, Panzner, U, Espinoza, LMC, Von Kalckreuth, V, Im, J, Schütt-Gerowitt, H, Crump, JA, Breiman, RF, Adu-Sarkodie, Y, Owusu-Dabo, E, Rakotozandrindrainy, R, Soura, AB, Aseffa, A, Gasmelseed, N, Keddy, KH, May, J, Sow, AG, Aaby, P, Biggs, HM, Hertz, JT, Montgomery, JM, Cosmas, L, Olack, B, Fields, B, Sarpong, N, Razafindrabe, TJL, Raminosoa, TM, Kabore, LP, Sampo, E, Teferi, M, Yeshitela, B, Tayeb, MA, Sooka, A, Meyer, CG, Krumkamp, R, Dekker, DM, Jaeger, A, Poppert, S, Tall, A, Niang, A, Bjerregaard-Andersen, M, Løfberg, SV, Seo, HJ, Jeon, HJ, Deerin, JF, Park, J, Konings, F, Ali, M, Clemens, JD, Hughes, P, Sendagala, JN, Vudriko, T, Downing, R, Ikumapayi, UN, Mackenzie, GA, Obaro, S, Argimon, S, Aanensen, DM, Page, A, Keane, JA, Duchene, S, Dyson, Z, Holt, KE, Dougan, G, Marks, F, Baker, S

Publikováno v: Nature Communications, Vol 9, Iss 1, Pp 1-10 (2018)
Nature Communications

There is paucity of data regarding the geographical distribution, incidence, and phylogenetics of multi-drug resistant (MDR) Salmonella Typhi in sub-Saharan Africa. Here we present a phylogenetic reconstruction of whole genome sequenced 249 contempor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a70d4d2745a317d27941cacc0e2e6e96
https://edoc.unibas.ch/67209/

Healthcare Seeking Behavior and Disease Perception Toward Cholera and Acute Diarrhea Among Populations Living in Cholera High-Priority Hotspots in Shashemene, Ethiopia.

Autor: Getahun T; Clinical Trials Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Hailu D; Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea.; School of Public Health, Hawassa University, Hawassa, Ethiopia., Mogeni OD; Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea., Mesfin Getachew E; Clinical Trials Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Yeshitela B; Bacterial and Viral Disease Research Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Jeon Y; Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea., Gedefaw A; Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea.; College of Medicine and Health Sciences, Hawassa University, Hawassa, Ethiopia., Ayele Abebe S; Statistics and Data Management Department, Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Hundito E; Clinical Trials Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Mukasa D; Biostatistics and Data Management (BDM) Department, International Vaccine Institute, Seoul, Republic of Korea., Jang GH; Biostatistics and Data Management (BDM) Department, International Vaccine Institute, Seoul, Republic of Korea., Pak GD; Biostatistics and Data Management (BDM) Department, International Vaccine Institute, Seoul, Republic of Korea., Kim DR; Biostatistics and Data Management (BDM) Department, International Vaccine Institute, Seoul, Republic of Korea., Worku Demlie Y; Public Health Emergency Management, Ethiopia Public Health Institute, Addis Ababa, Ethiopia., Hussen M; Public Health Emergency Management, Ethiopia Public Health Institute, Addis Ababa, Ethiopia., Teferi M; Clinical Trials Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Park SE; Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea.; Department of Global Health and Disease Control, Yonsei University Graduate School of Public Health, Seoul, Republic of Korea.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Jul 12; Vol. 79 (Supplement_1), pp. S43-S52.

Retrospective Analysis of Cholera/Acute Watery Diarrhea Outbreaks in Ethiopia From 2001 To 2023: Incidence, Case Fatality Rate, and Seasonal and Multiyear Epidemic Patterns.

Autor: Worku Demlie Y; Diseases Surveillance and Response Directorate, Ethiopia Public Health Institute, Addis Ababa, Ethiopia., Gedefaw A; Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea.; College of Medicine and Health Sciences, Hawassa University, Hawassa, Ethiopia., Jeon Y; Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea., Hailu D; Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea.; School of Public Health, Hawassa University, Hawassa, Ethiopia., Getahun T; Clinical Trials Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Mogeni OD; Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea., Mukasa D; Biostatistics and Data Management Department (BDM), International Vaccine Institute, Seoul, Republic of Korea., Jang GH; Biostatistics and Data Management Department (BDM), International Vaccine Institute, Seoul, Republic of Korea., Pak GD; Biostatistics and Data Management Department (BDM), International Vaccine Institute, Seoul, Republic of Korea., Kim DR; Biostatistics and Data Management Department (BDM), International Vaccine Institute, Seoul, Republic of Korea., Getachew EM; Clinical Trials Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Yeshitela B; Bacterial and Viral Disease Research Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Ayele Abebe S; Data Science Division, Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Edosa M; Diseases Surveillance and Response Directorate, Ethiopia Public Health Institute, Addis Ababa, Ethiopia., Wossen M; Diseases Surveillance and Response Directorate, Ethiopia Public Health Institute, Addis Ababa, Ethiopia., Teferi M; Clinical Trials Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Park SE; Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea.; Department of Global Health and Disease Control, Yonsei University Graduate School of Public Health, Seoul, Republic of Korea.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Jul 12; Vol. 79 (Supplement_1), pp. S8-S19.

Incidence of typhoid fever in Burkina Faso, Democratic Republic of the Congo, Ethiopia, Ghana, Madagascar, and Nigeria (the Severe Typhoid in Africa programme): a population-based study.

Autor: Marks F; International Vaccine Institute, Seoul, South Korea; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK; Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar. Electronic address: fmarks@ivi.int., Im J; International Vaccine Institute, Seoul, South Korea., Park SE; International Vaccine Institute, Seoul, South Korea; Yonsei University Graduate School of Public Health, Seoul, South Korea; Yonsei University Graduate School of Public Health, Seoul, South Korea., Pak GD; International Vaccine Institute, Seoul, South Korea., Jeon HJ; International Vaccine Institute, Seoul, South Korea; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar., Wandji Nana LR; Institut Supérieur des Sciences de la Population, Ouagadougou, Burkina Faso., Phoba MF; Department of Microbiology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; Department of Medical Biology, Microbiology Service, University Teaching Hospital of Kinshasa, University of Kinshasa, Kinshasa, Democratic Republic of the Congo., Mbuyi-Kalonji L; Department of Microbiology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; Department of Medical Biology, Microbiology Service, University Teaching Hospital of Kinshasa, University of Kinshasa, Kinshasa, Democratic Republic of the Congo., Mogeni OD; International Vaccine Institute, Seoul, South Korea., Yeshitela B; Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Panzner U; International Vaccine Institute, Seoul, South Korea., Cruz Espinoza LM; International Vaccine Institute, Seoul, South Korea., Beyene T; Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Owusu-Ansah M; School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana., Twumasi-Ankrah S; School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana; Department of Statistics and Actuarial Science, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana., Yeshambaw M; Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Alemu A; Department of Medicine, University of Ibadan, Ibadan, Nigeria., Adewusi OJ; College of Medicine, University of Ibadan, Ibadan, Nigeria., Adekanmbi O; Department of Medicine, University of Ibadan, Ibadan, Nigeria; Department of Community Medicine, University College Hospital, Ibadan, Nigeria., Higginson E; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK., Adepoju A; Department of Paediatrics, University of Ibadan, Ibadan, Nigeria; Department of Community Medicine, University College Hospital, Ibadan, Nigeria., Agbi S; Department of Medicine, University of Ibadan, Ibadan, Nigeria., Cakpo EG; Institut Supérieur des Sciences de la Population, Ouagadougou, Burkina Faso., Ogunleye VO; Department of Community Medicine, University College Hospital, Ibadan, Nigeria., Tunda GN; Department of Microbiology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; Faculty of Medicine, Congo Protestant University, Kinshasa, Democratic Republic of the Congo., Ikhimiukor OO; Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria., Mbuyamba J; Department of Microbiology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; Department of Medical Biology, Microbiology Service, University Teaching Hospital of Kinshasa, University of Kinshasa, Kinshasa, Democratic Republic of the Congo., Toy T; International Vaccine Institute, Seoul, South Korea., Agyapong FO; Department of Clinical Microbiology, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana., Osei I; Medical Research Council Unit, The Gambia at London School of Hygiene & Tropical Medicine, Banjul, The Gambia; Faculty of Infectious & Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK., Amuasi J; School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana; Bernhard Nocht Institute of Tropical Medicine, Hamburg, Germany; Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR), Kumasi, Ghana., Razafindrabe TJL; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar., Raminosoa TM; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar., Nyirenda G; International Vaccine Institute, Seoul, South Korea., Randriamampionona N; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar., Seo HW; International Vaccine Institute, Seoul, South Korea., Seo H; International Vaccine Institute, Seoul, South Korea., Siribie M; International Vaccine Institute, Seoul, South Korea., Carey ME; Department of Infection Biology, London School of Hygiene & Tropical Medicine, London, UK; International AIDS Vaccine Initiative, Chelsea & Westminster Hospital, London, UK., Owusu M; Department of Medical Diagnostics, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana; Centre for Health System Strengthening (CfHSS), Kumasi, Ghana; Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR), Kumasi, Ghana., Meyer CG; Institute of Tropical Medicine, Eberhard-Karls University Tübingen, Tübingen, Germany; Duy Tan University, Da Nang, Viet Nam., Rakotozandrindrainy N; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar., Sarpong N; School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana., Razafindrakalia M; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar., Razafimanantsoa R; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar., Ouedraogo M; Hôpital Protestant Schiphra, Ouagadougou, Burkina Faso., Kim YJ; International Vaccine Institute, Seoul, South Korea., Lee J; International Vaccine Institute, Seoul, South Korea; Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia., Zellweger RM; International Vaccine Institute, Seoul, South Korea., Kang SSY; International Vaccine Institute, Seoul, South Korea., Park JY; International Vaccine Institute, Seoul, South Korea; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK., Crump JA; Centre for International Health, University of Otago, Dunedin, New Zealand., Hardy L; Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium., Jacobs J; Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven Belgium., Garrett DO; Sabin Vaccine Institute, Washington, DC, USA., Andrews JR; Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA., Poudyal N; International Vaccine Institute, Seoul, South Korea., Kim DR; International Vaccine Institute, Seoul, South Korea., Clemens JD; International Vaccine Institute, Seoul, South Korea; Jonathan and Karin Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, USA., Baker SG; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK., Kim JH; International Vaccine Institute, Seoul, South Korea; Department of Life Sciences, College of Natural Sciences, Seoul National University, Seoul, South Korea., Dougan G; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK., Sugimoto JD; International Vaccine Institute, Seoul, South Korea; Epidemiologic Research and Information Center, Cooperative Studies Program, Office of Research and Development, United States Department of Veterans Affairs, Seattle, WA, USA; Department of Epidemiology, University of Washington, Seattle, WA, USA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle WA USA., Van Puyvelde S; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerpen, Belgium., Kehinde A; Department of Medical Microbiology and Parasitology, College of Medicine, University of Ibadan, Ibadan, Nigeria., Popoola OA; Department of Community Medicine, University College Hospital, Ibadan, Nigeria; Department of Community Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria., Mogasale V; International Vaccine Institute, Seoul, South Korea., Breiman RF; Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA; Infectious Diseases and Oncology Research Institute, University of the Witwatersrand, Johannesburg, South Africa., MacWright WR; Public Health Surveillance Group, Princeton, NJ, USA., Aseffa A; Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Tadesse BT; International Vaccine Institute, Seoul, South Korea; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden; Center for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia., Haselbeck A; International Vaccine Institute, Seoul, South Korea., Adu-Sarkodie Y; School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana; Department of Clinical Microbiology, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana., Teferi M; Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Bassiahi AS; Institut Supérieur des Sciences de la Population, Ouagadougou, Burkina Faso., Okeke IN; Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria., Lunguya-Metila O; Department of Microbiology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; Department of Medical Biology, Microbiology Service, University Teaching Hospital of Kinshasa, University of Kinshasa, Kinshasa, Democratic Republic of the Congo., Owusu-Dabo E; School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana., Rakotozandrindrainy R; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar.

Publikováno v: The Lancet. Global health [Lancet Glob Health] 2024 Apr; Vol. 12 (4), pp. e599-e610.

Characterization of Typhoid Intestinal Perforation in Africa: Results From the Severe Typhoid Fever Surveillance in Africa Program.

Autor: Birkhold M; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA., Datta S; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA., Pak GD; Epidemiology, Public Health, and Impact Unit (EPIC), International Vaccine Institute, Seoul, Republic of Korea., Im J; Epidemiology, Public Health, and Impact Unit (EPIC), International Vaccine Institute, Seoul, Republic of Korea., Ogundoyin OO; Division of Pediatric Surgery, University College Hospital and Department of Surgery, University of Ibadan, Ibadan, Nigeria., Olulana DI; Division of Pediatric Surgery, University College Hospital and Department of Surgery, University of Ibadan, Ibadan, Nigeria., Lawal TA; Division of Pediatric Surgery, University College Hospital and Department of Surgery, University of Ibadan, Ibadan, Nigeria., Afuwape OO; Division of Gastrointestinal Surgery, University College Hospital and Department of Surgery, University of Ibadan, Ibadan, Nigeria., Kehinde A; Department of Medical Microbiology and Parasitology, College of Medicine, University of Ibadan, Ibadan, Nigeria., Phoba MF; Department of Microbiology, Institut National de Recherche Biomedicales, Kinshasa, Democratic Republic of Congo., Nkoji G; Department of Microbiology, Institut National de Recherche Biomedicales, Kinshasa, Democratic Republic of Congo., Aseffa A; Armauer Hansen Research Institute, ALERT Campus, Addis Ababa, Ethiopia., Teferi M; Armauer Hansen Research Institute, ALERT Campus, Addis Ababa, Ethiopia., Yeshitela B; Armauer Hansen Research Institute, ALERT Campus, Addis Ababa, Ethiopia., Popoola O; Department of Community Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria., Owusu M; Department of Medical Diagnostics, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana., Nana LRW; Institut Supérieur des Sciences de la Population, Université Joseph Ki Zerbo, Ouagadougou, Burkina Faso., Cakpo EG; Institut Supérieur des Sciences de la Population, Université Joseph Ki Zerbo, Ouagadougou, Burkina Faso., Ouedraogo M; Laboratorie d'Analyses Medicales, Hopital Protestant Schiphra, Ouagadougou, Burkina Faso., Ouangre E; Service de Chirurgie Viscérale, Hopital Yalgado, Ouagadougou, Burkina Faso., Ouedraogo I; Pediatric Department, Hopital Charles de Gaulle, Ouagadougou, Burkina Faso., Heroes AS; Department of Tropical Bacteriology, Institute of Tropical Medicine, Antwerp, Belgium.; Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium., Jacobs J; Department of Tropical Bacteriology, Institute of Tropical Medicine, Antwerp, Belgium.; Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium., Mogeni OD; Epidemiology, Public Health, and Impact Unit (EPIC), International Vaccine Institute, Seoul, Republic of Korea., Haselbeck A; Epidemiology, Public Health, and Impact Unit (EPIC), International Vaccine Institute, Seoul, Republic of Korea., Sukri L; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA., Neuzil KM; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA., Metila OL; Department of Microbiology, Institut National de Recherche Biomedicales, Kinshasa, Democratic Republic of Congo.; Service de Microbiologie, Cliniques Universitaires de Kinshasa, Kinshasa, Democratic Republic of Congo., Owusu-Dabo E; Department of Medical Diagnostics, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana., Adu-Sarkodie Y; Department of Medical Diagnostics, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana., Bassiahi AS; Institut Supérieur des Sciences de la Population, Université Joseph Ki Zerbo, Ouagadougou, Burkina Faso., Rakotozandrindrainy R; Department of Microbiology and Parasitology, University of Antananarivo, Antananarivo, Madagascar., Okeke IN; Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria., Zellweger RM; Epidemiology, Public Health, and Impact Unit (EPIC), International Vaccine Institute, Seoul, Republic of Korea., Marks F; Epidemiology, Public Health, and Impact Unit (EPIC), International Vaccine Institute, Seoul, Republic of Korea.; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, United Kingdom.; Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany.; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar.

Publikováno v: Open forum infectious diseases [Open Forum Infect Dis] 2023 Jun 02; Vol. 10 (Suppl 1), pp. S67-S73. Date of Electronic Publication: 2023 Jun 02 (Print Publication: 2023).